Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2021 | Promosing future of immunotherapy for solid tumors

Julian R. Molina • 12 Nov 2021
SITC 2021
Lung Cancer Melanoma Skin Cancer

Julian Molina, MD, PhD, Mayo Clinic, Rochester, MN, emphasises the promising future of immunotherapy for solid tumors, especially melanoma and lung cancer. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

More from Julian R. Molina

0:48
Is CAR-T therapy the future of cancer treatment?
Julian R. Molina • 12 Nov 2021

Related Videos

0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
4:20
Insights from BTOG 2024: advancements in TNM Staging, systematic staging, & immunotherapy strategies
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals